RE:RE:RE:New CEO - Seasoned Healthcare Executive, Dr. Tushar RamaniA new CEO was definitely necessary, that is a good move. But until the new CEO announces some changes to their business model and how they are goiing to increase their margins and expand their offering its still the same company. Investing just based on a new CEO with pharma experience is a gamble, I don't think you can disagree with that. Undoubtedly change was needed but its tbd if the new CEO can do any better. Hopefully they get rid of Wrights massive unjustified compensation and bring the new CEO down to something more in line with performance then that is also an added benefit. Its a show me story at this point, lets see what happens.